Tag: ip1

JC: Does post exposure prophylaxis (with HCQ) work in Covid-19?

The utility of hydroxychloroquine in the management of Covid-19 often seems to be more of a political than a medical debate. Many politicians, journalists, hacks, and a whole range of social media experts have an

Covid-19 in Italy with Roberto Cosentini part 2. St Emlyn’s

Ed – Back at the beginning of the pandemic we had a fantastic contribution from our friend and colleague Roberto Cosentini on the Bergamo experience of dealing with this terrible disease. It turned out to

Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn’s

We have previously covered the RECOVERY trial on St Emlyn’s noting that the first results out of this large pragmatic, adaptive design platform RCT showed no benefit to Hydroxychloroquine. A few weeks ago a press

The RECOVERY platform trial: No benefit to Hydroxychloroquine in Covid-19. St Emlyn’s

We’ve talked about the RECOVERY trial on the blog and podcast before. This is a UK based platform trial (more on this later) looking at patients admitted to hospital with Covid-19. It’s an open label

Purposefully Practicing for COVID-19

“When” not “if” Purposeful Practice? To purposefully practice you must:– Deliberately target specific skills during shifts, seizing opportunities to drill or do them for real. – Push yourself out of the comfort zone.– Seek immediate feedback or self-reflect on stuff that can

COVID-19 and global health: a snapshot for Emergency Medicine

Editors:  James Chan @jameschanuk Global Emergency Care Fellow, ST5 in Emergency Medicine, Leeds Teaching Hospitals NHS Trust Anisa Jafar @EmergeMedGlobal NIHR Academic Lecturer and ST5 in Emergency Medicine, University of Manchester/Manchester Royal Infirmary There are

Translate »